Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Neovasc Inc. buy marge

Neovasc Inc.
Start price
€563.75
16.10.18 / 50%
Target price
€902.00
16.04.19
Performance (%)
-83.00%
End price
€95.84
16.04.19
Summary
This prediction ended on 16.04.19 with a price of €95.84. Massive losses of -83.00% were the result for the BUY prediction by marge. marge has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Neovasc Inc. - - - -
iShares Core DAX® 0.437% 5.897% 8.047% 65.579%
iShares Nasdaq 100 1.057% 0.920% 28.466% 90.185%
iShares Nikkei 225® 1.769% 1.228% 47.574% 84.991%
iShares S&P 500 0.368% 1.920% 23.200% 70.760%

Comments by marge for this prediction

In the thread Neovasc Inc diskutieren
Prediction Buy
Perf. (%) -83.00%
Target price 36.080
Change
Ends at 16.04.19

marge stimmt der Buy-Einschätzung von Thorsten_78 zu


10.10.2018 Neovasc announces that the FDA has granted Breakthrough Device designation to the Neovasc Reducer, a medical device for the treatment of refractory angina, which is not currently approved for commercial sale in the U.S.





marge 
0
Report Share
16.10.18
Prediction Buy
Perf. (%) -83.00%
Target price 36.080
Change
Ends at 16.04.19

(Laufzeit überschritten)

marge 
0
Report Share
16.04.19